BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22323641)

  • 1. Do we now have a prognostic biomarker for progressive diabetic nephropathy?
    Brosius FC; Saran R
    J Am Soc Nephrol; 2012 Mar; 23(3):376-7. PubMed ID: 22323641
    [No Abstract]   [Full Text] [Related]  

  • 2. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.
    Hollenberg NK
    Curr Hypertens Rep; 2001 Jun; 3(3):177. PubMed ID: 11421227
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
    Niewczas MA; Gohda T; Skupien J; Smiles AM; Walker WH; Rosetti F; Cullere X; Eckfeldt JH; Doria A; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):507-15. PubMed ID: 22266663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes and chronic kidney disease: lessons from renal epidemiology].
    Villar E; Zaoui P
    Nephrol Ther; 2010 Dec; 6(7):585-90. PubMed ID: 21075694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
    Gohda T; Niewczas MA; Ficociello LH; Walker WH; Skupien J; Rosetti F; Cullere X; Johnson AC; Crabtree G; Smiles AM; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):516-24. PubMed ID: 22266664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
    Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephropathy in patients with type 2 diabetes mellitus.
    Ritz E; Orth SR
    N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Developmental phases and diagnostic criteria in diabetic nephropathy].
    Duława J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):807-9. PubMed ID: 2096373
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic nephropathy in Japan.
    Shigeta Y; Kikkawa R
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S191-7. PubMed ID: 7859604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes.
    Harvey JN
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):317-22. PubMed ID: 12698072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural history of diabetic nephropathy].
    Ishimura E
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():324-30. PubMed ID: 15999728
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic Nephropathy: An Overview.
    Sagoo MK; Gnudi L
    Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes mellitus as cause of terminal renal failure. An epidemic of the 21st Century?].
    Carretero-Dios D; Pérez-García R; Rodríguez-Benítez P; Villaverde M; Gómez-Campderá F; Valderrábano F
    Nefrologia; 2001; 21 Suppl 3():83-7. PubMed ID: 11642212
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic nephropathy: a global and growing threat.
    Tang SC
    Hong Kong Med J; 2010 Aug; 16(4):244-5. PubMed ID: 20683064
    [No Abstract]   [Full Text] [Related]  

  • 16. End-stage renal disease in NIDDM: a consequence of microangiopathy alone?
    Raine AE; Bilous RW
    Diabetologia; 1996 Dec; 39(12):1673-5. PubMed ID: 9081854
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney disease of diabetes mellitus (diabetic nephropathy): perspectives in the United States.
    Striker GE; Agodoa LL; Held P; Doi T; Conti F; Striker LJ
    J Diabet Complications; 1991; 5(2-3):51-2. PubMed ID: 1770051
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of end-stage renal disease in patients with diabetes mellitus: from the dark ages to the middle ages.
    Catalano C; Marshall SM
    Nephrol Dial Transplant; 1992; 7(3):181-90. PubMed ID: 1314987
    [No Abstract]   [Full Text] [Related]  

  • 19. Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: new lessons from the RENAAL Study.
    Shahinfar S; Dickson T; Zhang Z; Keane WF; Brenner BM;
    Kidney Int Suppl; 2005 Jan; (93):S48-51. PubMed ID: 15663528
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of end-stage renal failure due to diabetes in the United Kingdom.
    Cameron JS
    J Diabetes Complications; 1992; 6(1):1-6. PubMed ID: 1562752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.